Anebulo Pharmaceuticals Inc 2024年度报告

Annual Report to Shareholders Anebulo Pharmaceuticals, Inc. 81,7('67$7(66(&85,7,(6$1'(;&+$1*(&200,66,21:$6+,1*721'& )250. 0DUN2QH ☒$118$/5(325738568$17726(&7,2125 G 2)7+(6(&85,7,(6(;&+$1*($&72) )RUWKHILVFDO\HDUHQGHG-XQH ☐75$16,7,215(325738568$17726(&7,2125 G 2)7+(6(&85,7,(6(;&+$1*($&72) 6HFXULWLHVUHJLVWHUHGSXUVXDQWWR6HFWLRQ E RIWKH$FW 6HFXULWLHVUHJLVWHUHGSXUVXDQWWR6HFWLRQ J RIWKH$FW1RQH ,QGLFDWHE\FKHFNPDUNLIWKH5HJLVWUDQWLVDZHOONQRZQVHDVRQHGLVVXHUDVGHILQHGLQ5XOHRIWKH6HFXULWLHV$FW<(6☐12☒ ,QGLFDWHE\FKHFNPDUNLIWKH5HJLVWUDQWLVQRWUHTXLUHGWRILOHUHSRUWVSXUVXDQWWR6HFWLRQRU G RIWKH$FW<(6☐12☒ ,QGLFDWHE\FKHFNPDUNZKHWKHUWKH5HJLVWUDQW  KDVILOHGDOOUHSRUWVUHTXLUHGWREHILOHGE\6HFWLRQRU G RIWKH6HFXULWLHV([FKDQJH$FWRIGXULQJWKHSUHFHGLQJPRQWKV RUIRUVXFKVKRUWHUSHULRGWKDWWKH5HJLVWUDQWZDVUHTXLUHGWRILOHVXFKUHSRUWV DQG  KDVEHHQVXEMHFWWRVXFKILOLQJUHTXLUHPHQWVIRUWKHSDVWGD\V<HV☒1R☐ ,QGLFDWHE\FKHFNPDUNZKHWKHUWKH5HJLVWUDQWKDVVXEPLWWHGHOHFWURQLFDOO\HYHU\,QWHUDFWLYH'DWD)LOHUHTXLUHGWREHVXEPLWWHGSXUVXDQWWR5XOHRI5HJXODWLRQ67 †RIWKLVFKDSWHU GXULQJWKHSUHFHGLQJPRQWKV RUIRUVXFKVKRUWHUSHULRGWKDWWKH5HJLVWUDQWZDVUHTXLUHGWRVXEPLWVXFKILOHV <HV☒1R☐ ,QGLFDWHE\FKHFNPDUNZKHWKHUWKH5HJLVWUDQWLVDODUJHDFFHOHUDWHGILOHUDQDFFHOHUDWHGILOHUDQRQDFFHOHUDWHGILOHUDVPDOOHUUHSRUWLQJFRPSDQ\RUDQHPHUJLQJJURZWKFRPSDQ\6HHWKHGHILQLWLRQVRI³ODUJHDFFHOHUDWHGILOHU´³DFFHOHUDWHGILOHU´³VPDOOHUUHSRUWLQJFRPSDQ\´DQG³HPHUJLQJJURZWKFRPSDQ\´LQ5XOHERIWKH([FKDQJH$FW ,IDQHPHUJLQJJURZWKFRPSDQ\LQGLFDWHE\FKHFNPDUNLIWKH5HJLVWUDQWKDVHOHFWHGQRWWRXVHWKHH[WHQGHGWUDQVLWLRQSHULRGIRUFRPSO\LQJZLWKDQ\QHZRUUHYLVHGILQDQFLDODFFRXQWLQJVWDQGDUGVSURYLGHGSXUVXDQWWR6HFWLRQ D RIWKH([FKDQJH$FW☐ ,QGLFDWHE\FKHFNPDUNZKHWKHUWKH5HJLVWUDQWKDVILOHGDUHSRUWRQDQGDWWHVWDWLRQWRLWVPDQDJHPHQW¶VDVVHVVPHQWRIWKHHIIHFWLYHQHVVRILWVLQWHUQDOFRQWURORYHUILQDQFLDOUHSRUWLQJXQGHU6HFWLRQ E RIWKH6DUEDQHV2[OH\$FW 86& EE\WKHUHJLVWHUHGSXEOLFDFFRXQWLQJILUPWKDWSUHSDUHGRULVVXHGLWVDXGLWUHSRUW☐ ,IVHFXULWLHVDUHUHJLVWHUHGSXUVXDQWWR6HFWLRQ E RIWKH$FWLQGLFDWHE\FKHFNPDUNZKHWKHUWKHILQDQFLDOVWDWHPHQWVRIWKHUHJLVWUDQWLQFOXGHGLQWKHILOLQJUHIOHFWWKHFRUUHFWLRQRIDQHUURUWRSUHYLRXVO\LVVXHGILQDQFLDOVWDWHPHQWV☐ ,QGLFDWHE\FKHFNPDUNZKHWKHUDQ\RIWKRVHHUURUFRUUHFWLRQVDUHUHVWDWHPHQWVWKDWUHTXLUHGDUHFRYHU\DQDO\VLVRILQFHQWLYHEDVHGFRPSHQVDWLRQUHFHLYHGE\DQ\RIWKHUHJLVWUDQW¶VH[HFXWLYHRIILFHUVGXULQJWKHUHOHYDQWUHFRYHU\SHULRGSXUVXDQWWR†' E ☐ ,QGLFDWHE\FKHFNPDUNZKHWKHUWKH5HJLVWUDQWLVDVKHOOFRPSDQ\ DVGHILQHGLQ5XOHERIWKH([FKDQJH$FW <HV☐1R☒ 7KHDJJUHJDWHPDUNHWYDOXHRIWKHYRWLQJDQGQRQYRWLQJFRPPRQVWRFNKHOGE\QRQDIILOLDWHVRIWKH5HJLVWUDQWZDVEDVHGRQWKHFORVLQJSULFHRIWKH5HJLVWUDQW¶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¶VFRPPRQVWRFNSDUYDOXHSHUVKDUHRXWVWDQGLQJDVRI6HSWHPEHUZDVVKDUHV '2&80(176,1&25325$7('%<5()(5(1&( $QHEXOR3KDUPDFHXWLFDOV,QF7DEOHRI&RQWHQWV 63(&,$/127(5(*$5',1*)25:$5'/22.,1*67$7(0(1766800$5<2)5,6.)$&72563$57,,WHP%XVLQHVV,WHP$5LVN)DFWRUV,WHP%8QUHVROYHG6WDII&RPPHQWV